$164.84
+0.76%Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Healthy operating margins demonstrate effective cost control and strong business fundamentals.
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
THC โข NYSE
| Tenet Healthcare Corporation Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
21.3B | 20.7B | 20.5B | 19.2B | 19.5B | 17.6B | 18.5B | 18.3B | 19.2B | 19.6B | 18.6B | 16.6B | 11.1B | 9.1B | 8.7B | 8.3B | 9B | 8.6B | 8.1B | 8.5B | |
GROSS PROFIT | ||||||||||||||||||||
(3.8B) | (12.5B) | (12.7B) | (12.1B) | (12.2B) | (11.4B) | (11.8B) | (11.7B) | (12.4B) | (12.5B) | (12B) | (10.7B) | (7.2B) | (5.8B) | (1.5B) | (1.5B) | (5.4B) | (5.3B) | (5B) | (5.3B) | |
17.5B | 8.2B | 7.8B | 7B | 7.3B | 6.2B | 6.7B | 6.7B | 6.8B | 7.1B | 6.7B | 6B | 3.9B | 3.3B | 7.1B | 6.7B | 3.6B | 3.3B | 3.1B | 3.1B | |
OPERATING INCOME | ||||||||||||||||||||
(14.1B) | (2.3B) | (5.3B) | (4.7B) | (4.4B) | (4.2B) | (5.2B) | (5B) | (5.7B) | (5.9B) | (5.6B) | (5B) | (3.3B) | (2.6B) | (6.5B) | (6.1B) | (3.6B) | (3.3B) | (3.1B) | (3.1B) | |
(8.7B) | (8.8B) | (418M) | (412M) | (412M) | (403M) | (344M) | (0.0) | (0.0) | (315M) | (248M) | (234M) | (186M) | (156M) | (0.0) | (0.0) | (0.0) | (0.0) | (2.6B) | (2.5B) | |
3.4B | 6B | 2.5B | 2.3B | 2.9B | 2B | 1.5B | 1.6B | 1.1B | 1.2B | 1.1B | 925M | 663M | 749M | 653M | 634M | 596M | 2.3B | 2.2B | -732M | |
PRE-TAX INCOME | ||||||||||||||||||||
(821M) | (826M) | (901M) | (890M) | (923M) | (1B) | (985M) | (1B) | (1B) | (979M) | (912M) | (754M) | (474M) | (412M) | (375M) | (424M) | (445M) | (418M) | (439M) | (1.3B) | |
-821M | -826M | -901M | -890M | -923M | -1B | -985M | -1B | -1B | -979M | -912M | -754M | -474M | -412M | -375M | -424M | -445M | -418M | -419M | 0.0 | |
(5.4B) | -6.5B | (4.9B) | (4.3B) | (4B) | (3.8B) | (4.8B) | (5B) | (5.7B) | (5.6B) | (5.4B) | (4.8B) | (3.1B) | (0.0) | (2.4B) | (2.3B) | (3.6B) | (3.3B) | (451M) | (695M) | |
-639M | -708M | -893M | -988M | -983M | -1.3B | -1.2B | -1B | -1.2B | -999M | -933M | -778M | -821M | -415M | -489M | -476M | -391M | -2.2B | -2.3B | -345M | |
2.8B | 5.2B | 1.6B | 1.3B | 1.9B | 671M | 320M | 629M | -101M | 248M | 144M | 147M | -158M | 334M | 164M | 158M | 205M | 54M | -96M | -1.1B | |
NET INCOME | ||||||||||||||||||||
(433M) | (1.2B) | (306M) | (344M) | (411M) | -97M | (160M) | (173M) | (219M) | (67M) | (68M) | (49M) | -65M | (125M) | (61M) | -977M | -23M | -25M | -61M | -262M | |
1.4B | 3.2B | 611M | 411M | 914M | 399M | -215M | 104M | -704M | -192M | -140M | 12M | -134M | 152M | 82M | 1.1B | 187M | 25M | -89M | -803M |
THC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 29, 2026 | May 27, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 16, 2026 | May 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 10, 2026 | April 09, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 25, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 17, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 11, 2026 | February 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 02, 2026 | January 27, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 24, 2025 | November 21, 2025 | 2025 |
Continue your THC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.